drugset / Trial / NCT00562614
Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose is to determine the effect of SLx-2101 dosed at 5mg or 10mg for 14 days on systolic, diastolic pressures and heart rate in patients with hypertension.
Timeline
- Start
- 2007-06
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SLx-2101 | Unknown | 5 mg | Oral |
| Subject | SLx-2101 | Unknown | 10 mg | Oral |